Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 5;4(2):185-192.
doi: 10.1002/hep4.1446. eCollection 2020 Feb.

Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery

Affiliations

Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery

Alina M Allen et al. Hepatol Commun. .

Abstract

Disease monitoring in nonalcoholic steatohepatitis (NASH) is limited by absence of noninvasive biomarkers of disease regression or progression. We aimed to examine the role of multiparametric three-dimensional magnetic resonance elastography (3D-MRE) and magnetic resonance imaging proton density fat fraction (MRI-PDFF) in the detection of NASH regression after interventions. This is a single-center prospective clinical trial of 40 patients who underwent bariatric surgery. Imaging and liver biopsies were obtained at baseline and 1 year after surgery. The imaging protocol consisted of multifrequency 3D-MRE to determine the shear stiffness at 60 Hz and damping ratio at 40 Hz, and MRI-PDFF to measure the fat fraction. A logistic regression model including these three parameters was previously found to correlate with NASH. We assessed the model performance in the detection of NASH resolution after surgery by comparing the image-predicted change in NAFLD activity score (delta NAS) to the histologic changes. A total of 38 patients (median age 43, 87% female, 30 of 38 with NAS ≥ 1, and 13 of 38 with NASH) had complete data at 1 year. The NAS decreased in all subjects with NAS ≥ 1 at index biopsy, and NASH resolved in all 13. There was a strong correlation between the predicted delta NAS by imaging and the delta NAS by histology (r = 0.73, P < 0.001). The strength of correlation between histology and the predicted delta NAS using single conventional parameters, such as the fat fraction by MRI-PDFF or shear stiffness at 60 Hz by MRE, was r = 0.69 (P < 0.001) and r = 0.43 (P = 0.009), respectively. Conclusion: Multiparametric 3D-MRE and MRI-PDFF can detect histologic changes of NASH resolution after bariatric surgery. Studies in a nonbariatric setting are needed to confirm the performance as a composite noninvasive biomarker for longitudinal NASH monitoring.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of NAFLD activity scores before and after weight‐loss surgery.
Figure 2
Figure 2
Histologic NAS at the time of bariatric surgery (index) and 1 year after.
Figure 3
Figure 3
Correlation between changes in NAFLD activity score by histology (x‐axis) and changes predicted by imaging (y‐axis). (A) Multiparametric 3D‐MRE and MRI‐PDFF. (B) MRI‐PDFF. (C) Single‐parameter 3D‐MRE (shear stiffness). Change was determined by subtracting the postbariatric surgery NAS from prebariatric NAS.
Figure 4
Figure 4
Longitudinal assessment of NASH probability and NAS prediction by multiparametric 3D‐MRE and MRI‐PDFF in 3 study patients. The three imaging parameters included in the predictive model are shown: mf3D‐MRE depiction of shear stiffness, mf3D‐MRE depiction of damping ratio, and MRI‐PDFF depiction of fat fraction. The horizontal boxes illustrate the predicted NAS values ranging from 0 to 8. The shaded part of the boxes represents the predicted range of NAS, which were derived from the regression model as the highest probabilities within the 68% CI.

References

    1. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle‐aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124‐131. - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73‐84. - PubMed
    1. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta‐analysis of paired‐biopsy studies. Clin Gastroenterol Hepatol 2015;13:643‐654.e641‐649; quiz e639‐640. - PMC - PubMed
    1. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, et al. The role of 3D‐MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery. Hepatology 2018. Dec 24. 10.1002/hep.30483. - DOI - PMC - PubMed
    1. ClinicalTrials.gov . Identifier NCT02565446, Transforming Non‐Invasive Liver Disease Detection by MRE: The Hepatogram. Bethesda, MD: National Library of Medicine; https://clinicaltrials.gov/ct2/show/NCT02565446?term=NCT02565446&draw=2&.... Accessed October 1, 2015.